Top

World Journal of Surgery

Published in:

01-03-2015

Antireflux Surgery for Dysplastic Barrett

Authors: Marco E. Allaix, Marco G. Patti

Published in: World Journal of Surgery | Issue 3/2015

Abstract

Introduction

Barrett’s esophagus (BE) is the result of continuous injury of the esophageal mucosa by gastric refluxate. This condition can progress to low-grade (LGD) and high-grade dysplasia (HGD) and eventually to adenocarcinoma. While excellent results are reported in terms of reflux and symptom control in patients with BE undergoing antireflux surgery (ARS), the impact of a fundoplication on progression and regression of dysplasia is debated. The aim of this article is to review the effects of ARS on regression and progression of LGD to HGD or cancer in patients with dysplastic BE.

Materials and Methods

A review of the literature in PubMed/Medline electronic databases has been performed.

Results

ARS might decrease but not eliminate the risk of progression to dysplasia or cancer in BE patients. ARS may promote regression of dysplastic BE only in short-segment BE, but not in long-segment BE. Modulation of gene expression is involved in the genesis and reversion of short-segment intestinal metaplasia after ARS.

Conclusions

Close and long-term surveillance by 24-hour pH monitoring and upper endoscopy is recommended in BE patients who undergo ARS to identify postoperative pathological reflux, and to early detect dysplasia or even adenocarcinoma. Further studies are requested to assess the molecular effects of ARS in dysplastic BE.

Dent J, El Serag HB, Wallander MA et al (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54:710–717CrossRefPubMedCentralPubMed

Patti MG, Arcerito M, Feo CV et al (1999) Barrett’s esophagus: a surgical disease. J Gastrointest Surg 3:397–403CrossRefPubMed

Rugge M, Zaninotto G, Parente P et al (2012) Barrett’s esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA). Ann Surg 256:788–794CrossRefPubMed

Oh DS, DeMeester SR (2010) Pathophysiology and treatment of Barrett’s esophagus. World J Gastroenterol 16:3762–3772CrossRefPubMedCentralPubMed

Dallemagne B, Weerts J, Markiewicz S et al (2006) Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc 20:159–165CrossRefPubMed

Parrilla P, Martinez de Haro LF, Ortiz A et al (2003) Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg 237:291–298PubMedCentralPubMed

Katz PO, Zavala S (2010) Proton pump inhibitors in the management of GERD. J Gastrointest Surg 14(Suppl 1):S62–S66CrossRefPubMed

Tamhankar AP, Peters JH, Portale G et al (2004) Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg 8:890–897CrossRefPubMed

Blonski W, Vela MF, Castell DO (2009) Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy. J Clin Gastroenterol 43:816–820CrossRefPubMed

10.

Tutuian R, Vela MF, Hill EG et al (2008) Characteristics of symptomatic reflux episodes on acid suppressive therapy. Am J Gastroenterol 103:1090–1096CrossRefPubMed

11.

Corly DA, Kubo A, Zhao W et al (2010) Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 139:93–101CrossRef

12.

Abraham NS (2012) Proton pump inhibitors: potential adverse effects. Curr Opin Gastroenterol 28:615–620CrossRefPubMed

13.

Herbella FA, Tedesco P, Nipomnick I et al (2007) Effect of partial and total laparoscopic fundoplication on esophageal body motility. Surg Endosc 21:285–288CrossRefPubMed

14.

Katzka DA, Castell DO (1994) Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett’s esophagus. Am J Gastroenterol 89:989–991PubMed

15.

Attwood SE, Lundell L, Hatlebakk JG et al (2008) Medical or surgical management of GERD patients with Barrett’s esophagus: the LOTUS trial 3-year experience. J Gastrointest Surg 12:1646–1654CrossRefPubMed

16.

Kauer WK, Peters JH, DeMeester TR et al (1995) Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 222:525–531CrossRefPubMedCentralPubMed

17.

McCallum R, Polepalle S, Davenport K et al (1991) Role of anti-reflux surgery against dysplasia in Barrett’s esophagus. Gastroenterology 100:A121

18.

Katz D, Rothstein R, Schned A et al (1998) The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett’s esophagus. Am J Gastroenterol 93:536–541CrossRefPubMed

19.

Ortiz A, Martinez de Haro LF, Parrilla P et al (1996) Conservative treatment versus antireflux surgery in Barrett’s oesophagus: long-term results of a prospective study. Br J Surg 83:274–278CrossRefPubMed

20.

Öberg S, Wenner J, Johansson J et al (2005) Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 242:49–54CrossRefPubMedCentralPubMed

21.

Oelschlager BK, Barreca M, Chang L et al (2003) Clinical and pathologic response of Barrett’s esophagus to laparoscopic antireflux surgery. Ann Surg 238:458–464PubMedCentralPubMed

22.

Chang EY, Morris CD, Seltman AK et al (2007) The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus: a systematic review. Ann Surg 246:11–21CrossRefPubMedCentralPubMed

23.

Csendes A, Burdiles P, Braghetto I et al (2002) Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett’s esophagus: the need for long-term subjective and objective follow-up. Ann Surg 235:178–185CrossRefPubMedCentralPubMed

24.

O’Riordan JM, Byrne PJ, Ravi N et al (2004) Long-term clinical and pathologic response of Barrett’s esophagus after antireflux surgery. Am J Surg 188:27–33CrossRefPubMed

25.

Lagergren J, Viklund P (2007) Is esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux? World J Surg 31:465–469CrossRefPubMed

26.

Zehetner J, deMeester SR, Ayazi S et al (2010) Long-term follow-up after anti-reflux surgery in patients with Barrett’s esophagus. J Gastrointest Surg 14:1483–1491CrossRefPubMed

27.

Wang KK, Sampliner RE (2008) Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797CrossRefPubMed

28.

Gurski RR, Peters JH, Hagen JA et al (2003) Barrett’s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg 196:706–712CrossRefPubMed

29.

Rossi M, Barreca M, de Bortoli N et al (2006) Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus. A prospective study. Ann Surg 243:58–63

30.

Oh DS, DeMeester SR, Vallbohmer D et al (2007) Reduction of interleukin-8 gene expression in reflux esophagitis and Barrett’s esophagus with antireflux surgery. Arch Surg 142:554–559CrossRefPubMed

31.

Babar M, Ennis D, Abdel-Latif M et al (2010) Differential molecular changes in patients with asymptomatic long-segment Barrett’s esophagus treated by antireflux surgery or medical therapy. Am J Surg 199:137–143CrossRefPubMed

32.

Zaninotto G, Cassaro M, Pennelli G et al (2005) Barrett’s epithelium after antireflux surgery. J Gastrointest Surg 9:1253–1261CrossRefPubMed

33.

Zaninotto G, Parente P, Salvador R et al (2012) Long-term follow-up of Barrett’s epithelium: medical versus antireflux surgical therapy. J Gastrointest Surg 16:7–14CrossRefPubMed

Title: Antireflux Surgery for Dysplastic Barrett
Authors: Marco E. Allaix
Marco G. Patti
Publication date: 01-03-2015
Publisher: Springer US
Published in: World Journal of Surgery / Issue 3/2015
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-014-2632-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Antireflux Surgery for Dysplastic Barrett

Abstract

Introduction

Materials and Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Materials and Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2015

Use of a 90° Drill and Screwdriver for Rib Fracture Stabilization

Community-Based Assessment of Surgical Symptoms in a Low-Income Urban Population

Breast Cancer as a Model to Improve Outcome of Cancer Care in Low- and Middle-Income Countries

Big Data as the Universal Language for Barrett’s Esophagus

Prospective Randomized Controlled Trial on the Use of Flexible Reinforced Laryngeal Mask Airway (LMA) during Total Thyroidectomy: Effects on Postoperative Laryngopharyngeal Symptoms: Reply

Method of Bilateral Pleural Drainage by Single Blake Drain After Esophagectomy